A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's ...

IO Biotech said on Monday its experimental cancer vaccine, in combination with Merck's Keytruda, showed improvement in a late ...

Fox News senior medical analyst Dr. Marc Siegel discusses Health and Human Services Secretary Robert F. Kennedy Jr.

Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...

The vaccine doesn't prevent cancer from happening in the first place, but an early-phase trial found it could reduce the odds ...

A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...

The "off-the-shelf" vaccine has also shown promising results for pancreatic cancer. Since the U.S. Preventive Services Task ...